Ann: Admedus Finishes 2016 with Growing Revenue, page-29

Your posting history is probably more interesting than your hybernation. We are very lucky that the staggering majority of your posts are on AHZ, a stock you don't own. Nothing personal and this is not a criticism but merely an observation drawing myself to the conclusion that there was a Trojan horse that wasn't shabby, price suppression and people who open accounts purely to bash a stock, all be it deserved in the past.

So much has changed in the past few months and most has to be considered positive and there is definitely a change in the style and character of management. 12 months time we will know if we are truly going to be a genuine profit making biotech as opposed to a bottomless money pit.

Was dismayed with the AHZ Chrissy present last year but this one is certainly not the lump of coal with options that came last year. Have a great Christmas to all AHZ LTs and just know every share we get our hands on is one less to be toyed with and more will have to be paid for it when we are profitable and the big boys want in.